How should a 9 mm subsolid pulmonary nodule be managed in an adult without a cancer history?

Management of a 9mm Subsolid Nodule

For a 9mm subsolid nodule in an adult without cancer history, obtain a CT scan at 3-6 months to confirm persistence, then perform annual CT surveillance for 5 years if the nodule remains stable and any solid component stays below 6mm. 1

Initial Management Algorithm

The 2017 Fleischner Society guidelines provide the foundational approach for this scenario 1:

For Part-Solid Nodules ≥6mm:

• First step: CT at 3-6 months to confirm the nodule is persistent (not inflammatory/infectious)
• If persistent and solid component <6mm: Annual CT for 5 years
• If solid component ≥6mm develops: Consider resection, as this indicates high suspicion for invasive adenocarcinoma

For Pure Ground-Glass Nodules ≥6mm:

• First step: CT at 6-12 months to confirm persistence
• If persistent: CT every 2 years until 5 years of surveillance completed

Critical Decision Points

The 2024 AATS expert consensus provides important refinement for the 8-10mm range 2:

High-risk morphologic features at 9mm that should raise concern:

• Lobulated or spiculated margins
• Solid component >6mm
• Air bronchograms
• Adjacent pleural or vascular changes

If any of these features are present, you should decrease surveillance intervals and consider tissue sampling or resection based on patient factors rather than following routine surveillance 2.

Why the 8-9mm Range Matters

At 9mm, your nodule sits at a critical threshold. The AATS guidelines emphasize that subsolid nodules >8mm with evidence of growth warrant biopsy or limited resection if feasible 2. This is because:

• Growing part-solid nodules begin developing risk of lymph node metastasis when the solid component reaches 6mm
• At 8-9mm, nodules are typically large enough for digital palpation during VATS, making surgical localization feasible
• Part-solid nodules with solid components ≥6mm should be considered highly suspicious 1

Practical Surveillance Strategy

For your 9mm subsolid nodule without suspicious features:

1. Baseline confirmation scan: 3-6 months
2. If stable: Continue annual surveillance for 5 years total
3. Monitor specifically for:
   • Development or growth of solid component to ≥6mm
   • Increase in overall nodule size
   • Development of suspicious morphologic features

Use low-dose CT protocols to minimize cumulative radiation exposure over the multi-year surveillance period 2.

Common Pitfalls to Avoid

• Don't use thick-section CT: Requires ≤1.5mm (typically 1mm) contiguous thin sections to accurately characterize part-solid morphology 1. Thick sections can miss small solid components that change management.

• Don't ignore the solid component size: A 9mm part-solid nodule with a 7mm solid component requires much more aggressive management than one with a 3mm solid component 1, 2.

• Don't assume all subsolid nodules behave the same: Part-solid nodules carry higher risk than pure ground-glass nodules. Age also matters—risk of growth increases 4% per year of patient age 3.

When to Escalate Management

Proceed to biopsy or resection if:

• Solid component grows to ≥6mm
• Overall nodule demonstrates growth on surveillance
• High-risk morphologic features develop
• Patient preference after multidisciplinary discussion 2

The volume doubling time for invasive adenocarcinoma is shorter than for adenocarcinoma in situ, so growth kinetics matter 3.